3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine has been researched along with Liver Diseases in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Brouwer, KL; Cheeseman, SH; Eyster, E; Lemon, SM; Moore, KH; Opheim, K; Raasch, RH; van der Horst, CM | 1 |
1 trial(s) available for 3'-azido-3'-deoxy-5'-o-beta-glucopyranuronosylthymidine and Liver Diseases
Article | Year |
---|---|
Pharmacokinetics and bioavailability of zidovudine and its glucuronidated metabolite in patients with human immunodeficiency virus infection and hepatic disease (AIDS Clinical Trials Group protocol 062).
Topics: Administration, Oral; Adult; Antiviral Agents; Biological Availability; Female; HIV Infections; Humans; Injections, Intravenous; Liver Diseases; Male; Middle Aged; Zidovudine | 1995 |